Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | CLK2 | P49760 | 1/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4865183 | 0.74 | KCNH2 (0.32) | KCNH2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL9699601 | 0.73 | ADH5 (0.34) | — | |
| SCHEMBL4365445 | 0.69 | KEAP1 (0.35) | — | |
| SCHEMBL19971066 | 0.67 | PDE4A (0.36) | KCNH2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL9840423 | 0.67 | MEN1 (0.35) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL4864333 | 0.66 | TNF (0.36) | KDM4EALDH1A1HPGDHSD17B10TDP1 | |
| SCHEMBL6527025 | 0.66 | KCNH2 (0.34) | KCNH2 | |
| SCHEMBL7576603 | 0.65 | ALDH1A1 (0.37) | KDM4EALDH1A1HPGDALOX15MEN1 | |
| SCHEMBL28433333 | 0.64 | KCNH2 (0.35) | KCNH2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL13261712 | 0.64 | CYP19A1 (0.33) | ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1615645-B2 | A CRYSTALLINE FORM III OF ANHYDROUS MOXIFLOXACIN HYDROCHLORIDE AND A PROCESS FOR THE PREPARATION THEREOF | REDDYS LAB LTD DR (IN) | 2013-08-21 | — | — | EP | disclosed |
| EP-2113505-A1 | A crystalline form III of anhydrous moxifloxacin hydrochloride and processes for the preparation thereof | Dr. Reddy's Laboratories, Ltd. (IN) | 2009-11-04 | — | — | EP | disclosed |
| EP-1615645-B1 | A CRYSTALLINE FORM III OF ANHYDROUS MOXIFLOXACIN HYDROCHLORIDE AND A PROCESS FOR THE PREPARATION THEREOF | REDDYS LAB LTD DR (IN) | 2009-08-19 | — | — | EP | disclosed |
| US-7230006-B2 | Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof | REDDY'S LABORATORIES LIMITED (IN) | 2007-06-12 | — | — | US | disclosed |
| US-20050137227-A1 | Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof | DR. REDDY'S LABORATORIES LIMITED | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137227-A1 | Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof | CYP4F3, CYP2F1, CYP3A43 | KCNH2 2908/4885KDM4E 3151/4885ALDH1A1 3015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.